Immutep (IMMP) Non Operating Income (2012 - 2016)

Immutep's (IMMP) quarterly Non Operating Income came in at $1.2 million in Q4 2016, down 42.54% on a QoQ basis from $2.2 million in Q4 2012.

Immutep (IMMP) Non Operating Income (2012 - 2016) Analysis & Trends

Immutep (IMMP) has 2 years of Non Operating Income data on file, last reported at $1.2 million in Q4 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non Op. Inc. (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	234.30 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-53.64 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-51.63 Mn
10	Immutep	56.46 Mn	-8.63 Mn	-	-

Download Data

Date	Value
Dec 31, 2016	1.24 Mn
Dec 31, 2012	2.16 Mn